Peer Review Banner

Understanding Breast Cancer in Women of African Ancestry


Feature story Breast cancer is often thought of by the general public as a single disease, one affliction of many that might affect women of any race or age. Yet researchers have long understood that this is not the case, that breast cancer affects people of different ages and ethnicities in strikingly varied ways. What was not understood was why or how these differences occurred: was it genetic or environmental or a combination of the two? These are the questions that Olufunmilayo Olopade, M.D., Professor of Medicine and Director, Center for Clinical Cancer Genetics, wanted to answer when she partnered with researchers in Nigeria and Sénégal to begin a long-term comparison study of breast cancer in the African diaspora.

“This study was the beginning of an attempt to understand the genes that drive breast cancer, especially estrogen receptor negative breast cancer,” says Olopade. “We knew that this very aggressive type of breast cancer tended to affect young black women at a much higher rate, but we didn't know why. This study helped us begin to unlock that mystery.”

Using samples collected from 378 women in Nigeria and Sénégal and comparing them to a database of breast cancer tissue from 930 North American women from Canada, Olopade and her team were able to determine key differences between the two populations: one, that breast cancers in African women often stemmed from basal-like cells rather than luminal cells as is common in Caucasian women; and two, that breast cancers in African women were often estrogen receptor negative.

“Because of the international nature of our study, we are able to hypothesize that both genetic and environmental factors may play a role in the development of this type of breast cancer,” says Olopade. “This study provides clear evidence for a biological difference between breast cancers in Caucasian and African women.”

While this study has opened up new areas of breast cancer research, it has also caused people to take a second look at policy regarding preventative care and treatment. As this study indicates, women of African descent are more likely to develop breast cancer at a young age, making them less likely to receive early diagnosis or treatment, as standard procedure calls for annual mammograms after the age of 40. Additionally, as most of the breast cancers were found to be estrogen receptor negative, standard treatments with estrogen blocking drugs like tamoxifen cannot be part of an effective treatment plan.

“Currently we have no good understanding of how to best to treat young women with this type of breast cancer,” says Olopade. “These women have a different set of criteria that we must consider when treating them. Up until now, older white women have provided the base line information for breast cancer prevention and treatment, and this leaves a large portion of the population out of the equation. Hopefully our study will affect that in a positive way.”

Photo

Thumbnail of news story Research Initiatives Subcommittee Awards Seed Funding
Biomedical research is changing at a rapid pace, and answers to the key problems in biomedical science will come from interdisciplinary approaches uniting different fields in a common endeavor...

Thumbnail of news story
Division Launches New Education Initiatives
As medical science continues to find ways to extend human life, it is inevitable that issues related to aging will come to permeate nearly every discipline of biomedical study...

Thumbnail of news story
Understanding Breast Cancer in Women of African Ancestry
Breast cancer is often thought of by the general public as a single disease, one affliction of many that might affect women of any race or age. Yet researchers have long understood that this is not the case, that breast cancer affects people of different ages and ethnicities in strikingly varied ways..

Center for Biomedical Discovery
The Division of the Biological Sciences is proud to announce the that the Board of Trustees has approved the design of the Center for Biomedical Discovery...

Discoveries
Many organizations have attempted research collaborations involving scientists from around the country or globe, but few have succeeded in making it work like the Myelin Repair Foundation...

DEVELOPMENT
The Spark Discovery, Illuminate Life campaign has raised $456 million and is quickly approaching its goal of $550 million...

EDUCATION
The Lewellyn John and Harriet Manchester Quantrell Award for Excellence in Undergraduate Teaching is the nation’s oldest prize givenThe Lewellyn John and Harriet Manchester Quantrell Award for Excellence in Undergraduate Teaching is the nation’s oldest prize given..

FOREFRONT
An experimental drug developed in the early 1990s called GW5638 has helped researchers better understand why and how cancer-fighting drugs like tamoxifen are able to impact...

ACADEMIC AFFAIRS
Recent Recruitments and Appointments of Biological Sciences Division Faculty.

ACCOLADES
Recent Awards and Grants Information for Biological Sciences Division Faculty

BulletMore News & Events